118 related articles for article (PubMed ID: 37741707)
21. Corrigendum to 'Regulatory mechanisms of submerged macrophyte on bacterial community recovery in decabromodiphenyl ether contaminated sediment: Microbiological and metabolomic perspectives' [Environ. Pollut. 337 (2023) 122616].
Gao H; Chen J; Wang C; Wang P; Wang R; Feng B
Environ Pollut; 2024 Jan; 341():122870. PubMed ID: 37967506
[No Abstract] [Full Text] [Related]
22. Neurodevelopmental effects of decabromodiphenyl ether (BDE-209) and implications for the reference dose.
Goodman JE
Regul Toxicol Pharmacol; 2009 Jun; 54(1):91-104. PubMed ID: 19249332
[TBL] [Abstract][Full Text] [Related]
23. Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8].
Liu YR; Sun B; Zhu GH; Li WW; Tian YX; Wang LM; Zong SM; Sheng PZ; Li M; Chen S; Qin Y; Liu HJ; Zhou HG; Sun T; Yang C
Toxicol Appl Pharmacol; 2022 Jan; 435():115824. PubMed ID: 34890639
[No Abstract] [Full Text] [Related]
24. Corrigendum to "Di-(2-ethylhexyl) phthalate could disrupt the insulin signaling pathway in liver of SD rats and L02 cells via PPARγ" [ Toxicol Appl Pharmacol. 2017; 316:17-26. doi:10.1016/j. taap.2016.12.010].
Zhang W; Shen XY; Zhang WW; Chen H; Xu WP; Wei W
Toxicol Appl Pharmacol; 2022 Aug; 449():116091. PubMed ID: 35659896
[No Abstract] [Full Text] [Related]
25. Corrigendum to "A new rat model of neonatal bilirubin encephalopathy (kernicterus)" [J. Pharmacol. Toxicol. Methods 84 (2017) 44-50].
Amini N; Vousooghi N; Soleimani M; Samadikuchaksaraei A; Akbari M; Safakheil H; Atafimanesh P; Shahbazi A; Brouki Milan P; Ramezani S; Mozafari M; Joghataei MT
J Pharmacol Toxicol Methods; 2018; 92():95. PubMed ID: 29534860
[No Abstract] [Full Text] [Related]
26. PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.
Berthon AS; Szarek E; Stratakis CA
Front Cell Dev Biol; 2015; 3():26. PubMed ID: 26042218
[TBL] [Abstract][Full Text] [Related]
27. Corrigendum to "nAChRs-ERK1/2-Egr-1 signaling participates in the developmental toxicity of nicotine by epigenetically down-regulating placental 11β-HSD2" [Toxicol Appl Pharmacol. 2018 Apr 1;344:1-12.].
Zhou J; Liu F; Yu L; Xu D; Li B; Zhang G; Huang W; Li L; Zhang Y; Zhang W; Wang H
Toxicol Appl Pharmacol; 2022 Feb; 436():115864. PubMed ID: 34998854
[No Abstract] [Full Text] [Related]
28. A physiologically based model for the ingestion of chromium(III) and chromium(VI) by humans.
O'Flaherty EJ; Kerger BD; Hays SM; Paustenbach DJ
Toxicol Sci; 2001 Apr; 60(2):196-213. PubMed ID: 11248132
[TBL] [Abstract][Full Text] [Related]
29. Corrigendum to 'Embryotoxic and pharmacologic potency ranking of six azoles in the rat whole embryo culture by morphological and transcriptomic analysis' [Toxicol. Appl. Pharmacol., 322 (2017) 15-26].
Dimopoulou M; Verhoef A; Pennings J; van Ravenzwaay B; Rietjens IMCM; Piersma AH
Toxicol Appl Pharmacol; 2018 Sep; 355():287. PubMed ID: 29980297
[No Abstract] [Full Text] [Related]
30. The effects of decabromodiphenyl ether on glycolipid metabolism and related signaling pathways in mice.
Zhu Y; Li X; Liu J; Zhou G; Yu Y; Jing L; Shi Z; Zhou X; Sun Z
Chemosphere; 2019 May; 222():849-855. PubMed ID: 30743236
[TBL] [Abstract][Full Text] [Related]
31. Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104].
Ganapathy S; Li P; Fagman J; Yu T; Lafontant J; Zhang G; Chen C
Toxicol Appl Pharmacol; 2017 Jan; 314():118. PubMed ID: 27851896
[No Abstract] [Full Text] [Related]
32. Corrigendum to "Probabilistic Monte Carlo estimation for quantitative exposure assessment of lotion transfer via baby wipes usage" [Regul. Toxicol. Pharmacol. 79 (2016) 54-63].
Dey S; Carr GJ; Li L; Brink S; Zhou S
Regul Toxicol Pharmacol; 2016 Oct; 80():360-361. PubMed ID: 27590994
[No Abstract] [Full Text] [Related]
33. PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser
Weigand I; Ronchi CL; Vanselow JT; Bathon K; Lenz K; Herterich S; Schlosser A; Kroiss M; Fassnacht M; Calebiro D; Sbiera S
Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33608270
[TBL] [Abstract][Full Text] [Related]
34. Corrigendum to "Safety assessment and attenuation of cisplatin induced nephrotoxicity by tuberous roots of Boerhaavia diffusa" [Regul. Toxicol. and Pharmacol. 81 (2016) 341-352].
Karwasra R; Kalra P; Nag TC; Gupta YK; Singh S; Panwar A
Regul Toxicol Pharmacol; 2017 Aug; 88():367-368. PubMed ID: 28592367
[No Abstract] [Full Text] [Related]
35. Corrigendum to "Crotonaldehyde-induced vascular relaxation and toxicity: Role of endothelium and Transient receptor potential ankyrin-1 (TRPA1)" [Toxicol Appl Pharmacol. 398 (2020) 115012].
Jin L; Jagatheesan G; Lynch J; Guo L; Conklin DJ
Toxicol Appl Pharmacol; 2020 Aug; 401():115114. PubMed ID: 32598891
[No Abstract] [Full Text] [Related]
36. Corrigendum to "D-Ribose-L-Cysteine attenuates manganese-induced cognitive and motor deficit, oxidative damage, and reactive microglia activation" [Environ. Toxicol. Pharm. 93 (2022) 103872].
Akingbade GT; Ijomone OM; Imam A; Aschner M; Ajao MS
Environ Toxicol Pharmacol; 2023 Aug; 101():104185. PubMed ID: 37380526
[No Abstract] [Full Text] [Related]
37. Corrigendum to "Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury" [Toxicol Appl Pharmacol. 2017; 326:15-24. doi: 10.1016/j.taap.2017.04.013].
Huang D; Wang C; Duan Y; Meng Q; Liu Z; Huo X; Sun H; Ma X; Liu K
Toxicol Appl Pharmacol; 2022 Sep; 450():116133. PubMed ID: 35716766
[No Abstract] [Full Text] [Related]
38. Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis "Toxicol Appl Pharmacol. 2016;305:194-202".
Lin CF; Huang HL; Peng CY; Lee YC; Wang HP; Teng CM; Pan SL
Toxicol Appl Pharmacol; 2020 Jan; 387():114858. PubMed ID: 31843362
[No Abstract] [Full Text] [Related]
39. Corrigendum to "28-day somatic gene mutation study of 1-Bromopropane in female big blue® B6C3F1 Mice via whole-Body inhalation: Support for a carcinogenic threshold" [Regul. Toxicol. Pharmacol., 104 (2019) 1-7].
Stelljes M; Young R; Weinberg J
Regul Toxicol Pharmacol; 2020 Dec; 118():104814. PubMed ID: 33158580
[No Abstract] [Full Text] [Related]
40. Retraction notice to: “Antibacterial activity and in vitro cytotoxicity of extracts and fractions of Parkia biglobosa (Jacq.) Benth. stem bark and Ageratum conyzoides Linn. leaves” [Environ. Toxicol. Pharmacol. 34 (2012) 478–483].
Environ Toxicol Pharmacol; 2012 Sep; 34(2):R1. PubMed ID: 23346561
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
